A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/51 (2006.01) A61K 9/06 (2006.01) A61K 31/585 (2006.01) A61K 47/14 (2006.01)
Patent
CA 2509101
The invention relates to a topical nanoparticulate spironolactone formulation comprising nanoparticles having a mean diameter, measured by photon correlation spectroscopy, in the range of from about 300nm to about 900nm. The nanoparticles are incorporated into a crystalline network system comprising a dispersion of solid crystals of polar lipids, said lipids exposing their hydrophilic side outwards and their hydrophobic side inwards towards the spironolactone nanoparticles.
L'invention concerne une préparation topique de spironolactone nanoparticulaire, les nanoparticules ayant un diamètre moyen, mesuré par spectroscopie de corrélation des photons, d'environ 300 nm à 900 nm. Les nanoparticules sont incorporées dans un système de réseau cristallin comprenant une dispersion de cristaux solides de lipides polaires, lesdits lipides exposant leur côté hydrophile à l'extérieur et leur côté hydrophobe à l'intérieur vers les nanoparticules spironolactone.
Beck Petra
Cancade Patricia
Grenier Pascal
Nhamias Alain
Scherer Dieter
Heenan Blaikie Llp
Jagotec Ag
LandOfFree
A topical nanoparticulate spironolactone formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with A topical nanoparticulate spironolactone formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A topical nanoparticulate spironolactone formulation will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1760099